WEBIOMED
K-SkAI is developing an AI-enabled predictive analytics solution for healthcare. Webiomed is the first software product with artificial intelligence that passed technical and clinical trials and received permission for medical use in the Russian Federation. The main focus of Webiomed is disease risk management.
WEBIOMED
Industry:
Analytics Artificial Intelligence Big Data Health Care Hospital Machine Learning Personal Health Predictive Analytics
Founded:
2018-01-01
Address:
Petrozavodsk, Karelia, Russian Federation
Country:
Russian Federation
Website Url:
http://www.webiomed.ai
Total Employee:
11+
Status:
Active
Contact:
8 (800) 234-05-04
Email Addresses:
[email protected]
Total Funding:
2.07 M USD
Technology used in webpage:
SPF Font Awesome Domain Not Resolving Mobile Non Scaleable Content Euro Apple Mobile Web App Capable Ruby On Rails Token Smart App Banner AggregateRating Schema Rating Schema
Similar Organizations
Pieces
Pieces is a healthcare artificial intelligence and technology company.
Reporte Inmobiliario
Reporte Inmobiliario provides information on the real estate market and automatic valuation models based on artificial intelligence
Current Employees Featured
Founder
Investors List
Spartak Zabolotsky
Spartak Zabolotsky investment in Series A - Webiomed
Mail.ru Cloud Solutions
Mail.ru Cloud Solutions investment in Grant - Webiomed
Official Site Inspections
http://www.webiomed.ai
- Host name: 33.mcs.mail.ru
- IP address: 89.208.209.33
- Location: Russia
- Latitude: 55.7386
- Longitude: 37.6068
- Timezone: Europe/Moscow
More informations about "Webiomed"
AI-enabled predictive analytics and risk assessment in ... - Webiomed
The project "Application of artificial intelligence technology to identify patients at high risk of developing cardiovascular diseases in the Kirov region", implemented by the government of …See details»
Webiomed - Crunchbase Company Profile & Funding
K-SkAI is developing an AI-enabled predictive analytics solution for healthcare. Webiomed is the first software product with artificial intelligence that passed technical and clinical trials and …See details»
Webiomed - Org Chart, Teams, Culture & Jobs - The Org
View Webiomed's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. ... Join to edit. Join to edit. Webiomed offers …See details»
Webiomed is a leading Russian startup in the field of artificial ...
K-SkAI LLC, a resident of Skolkovo Foundation and the developer of the Webiomed machine learning-based predictive analytics and risk assessment platform for healthcare, took first …See details»
Webiomed - hefi.io
Webiomed is a leading Russian startup in the field of artificial intelligence for healthcare. The first AI-based Russian software in healthcare officially registered as a medical device. The first …See details»
Webiomed - Machine Learning-based Predictive Analytics and Risk ...
Jun 26, 2023 Product Webiomed - Machine Learning-based Predictive Analytics and Risk Management in Healthcare Platform, 2024 Launch of module allowing companies to obtain …See details»
Webiomed - Golden
Webiomed offers predictive analytics and risk management in healthcare based on artificial intelligence. ... webiomed.ai. Is a. Company. Organization. Company attributes. Industry. …See details»
Webiomed platform is the first Russian development in artificial ...
“The development strategy of Webiomed is based on the company's striving for maximum compliance with all the regulatory and technical requirements in the field of digital healthcare …See details»
Webiomed - Funding, Financials, Valuation & Investors - Crunchbase
Webiomed offers predictive analytics and risk management in healthcare based on artificial intelligence. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ...See details»
Webiomed - Company Profile - Tracxn
Aug 27, 2024 Webiomed ranks 39th among 164 active competitors. 28 of its competitors are funded while 4 have exited. Overall, Webiomed and its competitors have raised over $529M in …See details»
Products - webiomed.ru
AI-enabled predictive analytics and risk assessment in healthcare. Reliable digital physician assistant to identify high-risk patients Clinical decision support system Webiomed.DHRA. …See details»
Webiomed (Russia) Funding: $2.1M - Medical Startups
AI-enabled predictive analytics and risk score in... Menu BY DISEASE BY TECHNOLOGY BY COUNTRY. Webiomed. Last updated: August 13, 2024 ... Russia | Funding: $2.1M Website: …See details»
Webiomed - Products, Competitors, Financials, Employees, …
Webiomed is a company that focuses on predictive analytics and decision support systems in the healthcare sector. The company offers artificial intelligence-based services that assist in …See details»
Webiomed - Crunchbase
Webiomed offers predictive analytics and risk management in healthcare based on artificial intelligence.See details»
Webiomed became the first AI-based Russian software in …
Webiomed became the first AI-based Russian software in healthcare officially registered as a medical device 2 347. April 3, ... Webiomed became the first software product with artificial …See details»
Webiomed - CoBee Company Profile & Funding Rounds
K-SkAI is developing an AI-enabled predictive analytics solution for healthcare. Webiomed is the first software product with artificial intelligence that passed technical and clinical trials and …See details»
Webiomed
WebiomedSee details»
Webiomed - Updates, News, Events, Signals & Triggers - Crunchbase
Webiomed offers predictive analytics and risk management in healthcare based on artificial intelligence.See details»
Webiomed Pricing, Alternatives & More 2024 - Capterra
WEBIOMED is a reliable digital assistant in predicting health risks and suspected disease cases. It contributes to the reduction of morbidity and mortality and is an effective innovative tool for …See details»
He diagnosed his rare disease using Google. Now he hopes AI can …
1 day ago Ian Stedman champions using artificial intelligence to diagnose more people with rare diseases after it took him 32 years and extraordinary effort to pinpoint his own rare disease. …See details»